| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/04/2004 | CN1160127C Powdery pernasal compositions |
| 08/04/2004 | CN1160123C Use of ulinastatin in treating SARS and medicinal composition thereof |
| 08/04/2004 | CN1160122C Method of preparing oil-phase oral insulin preparation |
| 08/04/2004 | CN1160121C Growth hormone liposome for pig and its preparation method |
| 08/04/2004 | CN1160115C Irrigation solution and method for inhibition of pain, inflammation and spasm |
| 08/04/2004 | CN1160100C Ointment for treating burn and scald |
| 08/04/2004 | CN1160095C Antisanility health-care cream and its preparing process |
| 08/04/2004 | CN1160092C Ointment with relax the muscles and stimulate the blood circulation function and its preparation method |
| 08/04/2004 | CN1160079C Bubbling enteric coated preparations |
| 08/04/2004 | CN1160077C External-used medicine containing phosphonomycin calcium and its application |
| 08/04/2004 | CN1160076C Pharmaceutical composition comprising bisphosphonic acid |
| 08/04/2004 | CN1160074C Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters |
| 08/04/2004 | CN1160069C Palladium-substd. bacteriochlorophll derivatives and use thereof |
| 08/04/2004 | CN1160067C Ginkgo lactone capsule and its prepn. method |
| 08/04/2004 | CN1160066C Preparing process of freeze dried ginkgolactone injection |
| 08/04/2004 | CN1160064C Selective antibiotic composition |
| 08/04/2004 | CN1160063C Method for coating slow releasing coat of ibudilast sustained micropill |
| 08/04/2004 | CN1160062C Pharmaceutical formulation comprising omeprazole |
| 08/04/2004 | CN1160061C Core tablet for controlled release of gliclazide after oral administration |
| 08/04/2004 | CN1160060C Compressed compositions comprising clarified xanthan gum |
| 08/04/2004 | CN1160059C Process of generating submicron particles of water-insuluble compounds |
| 08/04/2004 | CN1160058C 附聚物 Agglomerates |
| 08/04/2004 | CN1160057C Microemlusions used as carriers for administration of active compounds |
| 08/04/2004 | CN1160056C Intravaginal clindamycin ovule composition |
| 08/04/2004 | CN1159988C Microcapsulized pine nut kernel powder and its making process |
| 08/03/2004 | US6772026 System and method for rapidly customizing design, manufacture and/or selection of biomedical devices |
| 08/03/2004 | US6770797 Inducing prolonged in vivo gene expression in a mammal for inhibiting alzheimer's disease associated neuronal cell death |
| 08/03/2004 | US6770725 Fluoroalkyl group coupled to oligomeric polymer for drug delivery |
| 08/03/2004 | US6770678 Warming (methylsulfonyl substituted-)-benzoylguanidine salt solution to accelerate dissolution; filtration, high speed freeze drying |
| 08/03/2004 | US6770675 Compositions and methods for reducing ocular hypertension |
| 08/03/2004 | US6770670 Injectable composition |
| 08/03/2004 | US6770660 Method for inhibiting platelet aggregation |
| 08/03/2004 | US6770635 Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions |
| 08/03/2004 | US6770623 Stabilized teriparatide solutions |
| 08/03/2004 | US6770621 Polyacid glycopeptide derivatives |
| 08/03/2004 | US6770619 Lung surfactant compositions with dynamic swelling behavior |
| 08/03/2004 | US6770459 Uses of polypeptides and polynucleotides that encode the compounds, such as vaccines against bacterial infections and for diagnostic assays for detecting infection of certain pathogens |
| 08/03/2004 | US6770368 Solid phase; drugs or foods; concurrent spray drying |
| 08/03/2004 | US6770305 Oral administration to counteract dehydration resulting from vomiting, diarrhea, physical exercise or illness; especially suitable for infants, small children and the elderly; water, sodium, potassium, citrate, carbonate and structuring |
| 08/03/2004 | US6770300 Rapidly decomposing chitosan-based pellets |
| 08/03/2004 | US6770299 Lipid matrix-drug conjugates particle for controlled release of active ingredient |
| 08/03/2004 | US6770298 Device for coating granules to be administered orally |
| 08/03/2004 | US6770297 Controlled release delivery system of solid dosage form |
| 08/03/2004 | US6770296 Hydrophilic core overcoated with hydrophobic hot melt lipid; for water soluble vitamins |
| 08/03/2004 | US6770295 Once-daily administration form, while maintaining the desired effect on the bladder, indeed gives a significant reduction of the (already low) side-effects, particularly dry mouth |
| 08/03/2004 | US6770294 Wrapping film for drugs, cosmetics, foods |
| 08/03/2004 | US6770293 Soft capsules comprising polymers of vinyl esters and polyethers, the use and production thereof |
| 08/03/2004 | US6770292 Pharmaceutical compositions for oral administration |
| 08/03/2004 | US6770291 Liposome complexes for increased systemic delivery |
| 08/03/2004 | US6770290 Amphotericin b liposomes formed have markedly reduced toxicity |
| 08/03/2004 | US6770289 For easy administration without the side effects |
| 08/03/2004 | US6770288 Cattle vaginal substance dispenser including a plurality of finger means configured to allow sustained release of substances over a period of time |
| 08/03/2004 | US6770263 Compositions and methods for the treatment of aches and pains |
| 08/03/2004 | US6770262 Intranasally administering metoclopramide or its salt for therapy or reducing the symptoms of gastroparesis in a patient |
| 08/03/2004 | US6770260 Mammal model contains a decreased level of endogenous macrophages sufficient to reduce depletion of non-autologous hematopoietic cells, achieved by administering an effective amount of dichloromethylene diphosphonate |
| 08/03/2004 | US6770067 Infusion device and driving mechanism for same |
| 08/03/2004 | CA2310207C Topical zinc compositions and methods of use |
| 08/03/2004 | CA2271095C Stabilised pharmaceutical compositions, with quinupristine and dalfopristine base and their preparation |
| 08/03/2004 | CA2233457C Pharmaceutical angiostatic dipeptide compositions and methods of use thereof |
| 08/03/2004 | CA2208155C Sugarfree hard coatings and a method for producing them |
| 08/03/2004 | CA2121065C External anti-inflammatory and analgesic plaster preparation |
| 08/03/2004 | CA2110161C Medetomidine preparations for transdermal administration |
| 08/03/2004 | CA2041093C A pharmacological composition containing polyelectrolyte complexes in microparticulate form and at least one active substance |
| 07/31/2004 | CA2447985A1 Medicament ejector with ejection port servicing |
| 07/29/2004 | WO2004063876A2 Programmed pulsed infusion methods and devices |
| 07/29/2004 | WO2004063705A2 Liquid-liquid interfacial nanoparticle assemblies |
| 07/29/2004 | WO2004063216A1 Conjugate for retention in blood and cancer tissue-specific drug delivery |
| 07/29/2004 | WO2004063152A2 Lansoprazole formulations and related processes and methods |
| 07/29/2004 | WO2004063024A2 Floral packaging material having prints thereon |
| 07/29/2004 | WO2004062712A2 Implantable interface system |
| 07/29/2004 | WO2004062695A1 Orally deliverable pharmaceutical composition containing protein pump inhibitors |
| 07/29/2004 | WO2004062692A1 Formulation of poorly water-soluble active substances |
| 07/29/2004 | WO2004062673A1 Anti-protozoal compositions comprising diclazuril |
| 07/29/2004 | WO2004062669A1 Use of a macrolide compound for treating dry eye |
| 07/29/2004 | WO2004062668A1 Ophthalmic compositions containing loratadine |
| 07/29/2004 | WO2004062660A1 Contact lens and eye drop rewetter compositions and their uses |
| 07/29/2004 | WO2004062656A1 Compositions and methods for improving the condition of patients suffering from copd and other diseases |
| 07/29/2004 | WO2004062651A1 Pharmaceutical aerosol composition |
| 07/29/2004 | WO2004062650A2 Moulded body made from a gelatine-free material filled with a liquid filling |
| 07/29/2004 | WO2004062649A2 Biodegradable ocular implant |
| 07/29/2004 | WO2004062648A1 Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties |
| 07/29/2004 | WO2004062647A1 Simple tablet compression using gelatin |
| 07/29/2004 | WO2004062646A1 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants |
| 07/29/2004 | WO2004062645A1 Microspheres containing amphotericin b |
| 07/29/2004 | WO2004062644A1 Granulate comprising an oily substance, corresponding production method and tablet |
| 07/29/2004 | WO2004062643A1 Dry dispersions |
| 07/29/2004 | WO2004062642A1 Pharmaceutical safety dosage forms |
| 07/29/2004 | WO2004062640A2 Capsule for receiving an active substance which is administrable by inhalation |
| 07/29/2004 | WO2004062639A1 Chewing gum composition with vegetal additives |
| 07/29/2004 | WO2004062632A1 Topical stabilized prostaglandin e compound dosage forms |
| 07/29/2004 | WO2004062628A2 Gilsonite derived pharmaceutical delivery compositions and methods |
| 07/29/2004 | WO2004062626A2 Composition and method for treating age-related disorders |
| 07/29/2004 | WO2004062617A2 Composition and method for treatment of bacterial vaginal infections |
| 07/29/2004 | WO2004062616A2 Method of treating cognitive decline due to sleep deprivation and stress |
| 07/29/2004 | WO2004062604A2 Treatment of cancer with 2-deoxyglucose |
| 07/29/2004 | WO2004062603A2 Methods of treating lung diseases |
| 07/29/2004 | WO2004062600A2 Antiviral patch |
| 07/29/2004 | WO2004062577A2 Two or more enteric materials to regulate drug release |
| 07/29/2004 | WO2004062569A2 Cardiolipin compositions their methods of preparation and use |
| 07/29/2004 | WO2004062564A2 Sedative non-benzodiazepine formulations |